# Prediction of the PRONOUNCE Prostate Cancer Trial in Healthcare Claims Data

> **NCT04897958** · — · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 14417 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Degarelix
- **DRUG:** Leuprolide

## Key facts

- **NCT ID:** NCT04897958
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-21
- **Primary completion:** 2021-08-01
- **Final completion:** 2021-08-01
- **Target enrollment:** 14417 (ACTUAL)
- **Last updated:** 2023-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04897958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04897958, "Prediction of the PRONOUNCE Prostate Cancer Trial in Healthcare Claims Data". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04897958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*